Copyright
©2009 The WJG Press and Baishideng. All rights reserved.
World J Gastroenterol. May 7, 2009; 15(17): 2078-2080
Published online May 7, 2009. doi: 10.3748/wjg.15.2078
Published online May 7, 2009. doi: 10.3748/wjg.15.2078
Tropheryma whipplei Infection
Hugh James Freeman, Department of Medicine (Gastroen-terology), University of British Columbia, Vancouver V6T 1W5, Canada
Author contributions: Freeman HJ contributed the entire paper.
Correspondence to: Dr. Hugh James Freeman, MD, FRCPC, FACP, Department of Medicine (Gastroenterology), University of British Columbia Hospital, 2211 Wesbrook Mall, Vancouver V6T 1W5, Canada. hugfree@shaw.ca
Telephone: +1-604-8227216
Fax: +1-604-8227236
Received: March 11, 2009
Revised: April 7, 2009
Accepted: April 14, 2009
Published online: May 7, 2009
Revised: April 7, 2009
Accepted: April 14, 2009
Published online: May 7, 2009
Abstract
Whipple’s disease was initially described in 1907. Over the next century, the clinical and pathological features of this disorder have been better appreciated. Most often, weight loss, diarrhea, abdominal and joint pain occur. Occasionally, other sites of involvement have been documented, including isolated neurological disease, changes in the eyes and culture-negative endocarditis. In the past decade, the responsible organism Tropheryma whipplei has been cultivated, its genome sequenced and its antibiotic susceptibility defined. Although rare, it is a systemic infection that may mimic a wide spectrum of clinical disorders and may have a fatal outcome. If recognized, prolonged antibiotic therapy may be a very successful form of treatment.
Keywords: Tropheryma whipplei; Small intestinal malabsorption; Abdominal lymphadenopathy; Periodic acid-Schiff staining; Whipple’s disease